$0.24
Today
as of Sep 4, 16:56 ET
Last 30 days
Recent Press Releases & News
Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
SRX Global (SRXH) Acquires Stake in Vistagen Therapeutics
Overview
52-week range
$0.20
$5.14
1% of range
Avg surprise (last 2)
+8.7%
Avg reaction (last 1)
+0.8%
100% positive
Latest IV / EM
1319%
EM ±227.2% · $1 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.30 | — | — | — | — | financials |
| Wed Dec 31, 2025 | Dec 2025 | $-0.45 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.54 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.47 | $-0.47 | 0.0% | — | — | earnings |
| Tue Jun 17, 2025 | Mar/2025 | $-0.43 | $-0.52 | +17.3% | — | +0.8% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-0.46 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.42 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.35 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.22 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.66 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.94 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | — | $303,000 | $258,000 | $244,000 | — | $234,000 | $183,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-13M | — | $-20M | $-20M | $-16M | — | $-15M | $-14M |
| Net income | $-13M | — | $-19M | $-19M | $-15M | — | $-14M | $-13M |
| EPS (diluted) | $-0.30 | — | $-0.45 | $-0.54 | $-0.47 | — | $-0.46 | $-0.42 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $17M | $31M | $47M | $63M | $49M | $67M | $75M | $84M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $34M | $47M | $63M | $79M | $67M | $82M | $90M | $100M |
| Total assets | $36M | $49M | $65M | $81M | $69M | $84M | $92M | $102M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $11M | $13M | $14M | $15M | $12M | $14M | $11M | $10M |
| Total equity | $24M | $36M | $51M | $66M | $57M | $70M | $81M | $93M |